|
|
Article: FDA approves cochlear implant designed for individuals with ossified cochlea.(Nucleus 24 Double Array from Cochlear Americas)
- Article from:
- Medical Devices & Surgical Technology Week
- Article date:
- August 4, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 AUG 4 - (NewsRx.com & NewsRx.net) -- Cochlear Americas announced that the U.S. Food and Drug Administration (FDA) approved the Nucleus 24 Double Array cochlear implant for use in patients with ossification (bone growth) in their cochlea (inner ear). This bone growth may block the space inside the cochlea preventing the use of conventional cochlear implants, which consist of a single array of electrodes.
The Nucleus 24 Double Array allows patients with significantly ossified cochlea to gain the benefits of cochlear implantation by offering two shorter electrode arrays. Unlike a single electrode array, these shorter electrodes arrays are surgically implanted ...
Related newspaper, magazine, and journal articles:
|
|
Article: Cochlear Americas Announces New Products for the ...
PR Newswire;
July 24, 2007 ;
700+ words
... ... DENVER, July 24 /PRNewswire/ -- Cochlear Americas today announced the availability ... said Chris Smith, President, Cochlear Americas. "Moreover, these accessories ... FreedomForKids for more information. About Cochlear Americas Since launching the world's first ...
|
|